Vascular wall regulator of G-protein signaling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control

Jyoti Patel, Surawee Chuaiphichai, Gillian Douglas, Caroline M Gorvin, Keith M Channon

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
86 Downloads (Pure)

Abstract

G-Protein coupled receptors (GPCRs) activate intracellular signalling pathways by coupling to heterotrimeric Gproteins that control many physiological processes including blood pressure homeostasis. The Regulator of G-Protein Signalling-1 (RGS1) controls the magnitude and duration of downstream GPCR signalling by acting as a GTPase activating protein for specific Gα-proteins. RGS1 has contrasting roles in haematopoietic and non-haematopoietic cells. Rgs1-/-ApoE-/- mice are protected from Angiotensin II (Ang II)-induced aortic aneurysm rupture. Conversely, Ang II treatment increases systolic blood pressure to a greater extent in Rgs1-/-ApoE-/- mice than ApoE-/- mice, independent of its role in myeloid cells. However the precise role of RGS1 in hypertension and vascular-derived cells remains unknown. We determined the effects of Rgs1 deletion on vascular function in ApoE-/- mice. Rgs1 deletion led to enhanced vasoconstriction in aortas and mesenteric arteries from ApoE-/- mice in response to phenylephrine (PE) and U46619 respectively. Rgs1 was shown to have a role in the vasculature, with endothelium-dependent vasodilation being impaired, and endothelium-independent dilatation to SNP being enhanced in Rgs1-/-ApoE-/- mesenteric arteries. To address the downstream signalling pathways in vascular smooth muscle cells (VSMCs) in response to Ang II-stimulation, we assessed pErk1/2, pJNK and pp38 MAPK activation in VSMCs transiently transfected with Rgs1. pErk1/2 signalling but not pJNK and pp38 signalling was impaired in the presence of Rgs1. Furthermore, we demonstrated that the enhanced contractile response to PE in Rgs1-/-ApoE-/- aortas was reduced by a MAPK/Erk (MEK) inhibitor and an L-type voltage gated calcium channel antagonist, suggesting that Erk1/2 signalling and calcium influx are major effectors of Rgs1-mediated vascular contractile responses, respectively . These findings indicate RGS1 is a novel regulator of blood pressure homeostasis and highlight RGS1-controlled signalling pathways in the vasculature that may be new drug development targets for hypertension.
Original languageEnglish
JournalVascular Pharmacology
Early online date11 Apr 2018
DOIs
Publication statusE-pub ahead of print - 11 Apr 2018

Fingerprint

Dive into the research topics of 'Vascular wall regulator of G-protein signaling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control'. Together they form a unique fingerprint.

Cite this